Published in Facial Plast Surg Clin North Am on November 01, 2001
Vascular malformations and hemangiolymphangiomas of the gastrointestinal tract: morphological features and clinical impact. Int J Clin Exp Pathol (2011) 1.91
Vascular anomalies: classification, imaging characteristics and implications for interventional radiology treatment approaches. Br J Radiol (2014) 1.02
Sclerotherapy for the treatment of infantile hemangiomas. J Cutan Aesthet Surg (2012) 0.99
Bleomycin induces endothelial mesenchymal transition through activation of mTOR pathway: a possible mechanism contributing to the sclerotherapy of venous malformations. Br J Pharmacol (2013) 0.93
Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors. Am J Surg Pathol (2012) 0.88
Treatment of lymphatic malformations of head and neck with OK-432 sclerotherapy induce systemic inflammatory response. Eur Arch Otorhinolaryngol (2010) 0.84
Radiographic findings associated with vascular anomalies. Semin Plast Surg (2014) 0.84
Paediatric interventional radiology. Pediatr Radiol (2009) 0.81
Low concentration of rapamycin inhibits hemangioma endothelial cell proliferation, migration, and vascular tumor formation in mice. Curr Ther Res Clin Exp (2014) 0.78
Familial blue rubber bleb nevus syndrome in pregnancy with spinal epidural involvement. Case Rep Obstet Gynecol (2013) 0.75
Can we predict the outcome of 595-nm wavelength pulsed dye laser therapy on capillary vascular malformations from the first beginning: a pilot study of efficacy co-related factors in 686 Chinese patients. Lasers Med Sci (2014) 0.75
Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg (1982) 12.85
Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell (1997) 7.47
Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell (1996) 5.10
Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med (1992) 4.76
Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg (1998) 3.42
Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation. Am J Med Genet (1999) 3.02
Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg (1999) 2.99
Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest (1994) 2.97
A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell (1993) 2.80
Hemangiomas and vascular malformations of infancy and childhood. Pediatr Clin North Am (1993) 2.69
Vascular tumors and vascular malformations (new issues). Adv Dermatol (1997) 2.48
A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet (1997) 2.22
Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg (1983) 2.20
Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest (2001) 2.20
Nonsyndromic cleft lip with or without cleft palate: evidence of linkage to BCL3 in 17 multigenerational families. Am J Hum Genet (1995) 2.12
Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a. Pediatrics (1999) 2.12
Pyogenic granuloma (lobular capillary hemangioma): a clinicopathologic study of 178 cases. Pediatr Dermatol (1991) 1.96
Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr (1998) 1.95
Application of the biological principle of induced osteogenesis for craniofacial defects. Lancet (1981) 1.92
Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. Am J Hum Genet (1999) 1.88
Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis. Hum Mol Genet (2000) 1.84
Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet (1994) 1.83
Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology (2000) 1.82
Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am J Hum Genet (2001) 1.81
Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg (1997) 1.76
Donor-site morbidity after harvesting rib and iliac bone. Plast Reconstr Surg (1984) 1.67
Childhood hemangiomas and vascular malformations: angiographic differentiation. AJR Am J Roentgenol (1983) 1.64
A gene for familial venous malformations maps to chromosome 9p in a second large kindred. J Med Genet (1995) 1.59
Vascular anomalies of the maxillofacial region. J Oral Maxillofac Surg (1986) 1.57
KRIT1 is mutated in hyperkeratotic cutaneous capillary-venous malformation associated with cerebral capillary malformation. Hum Mol Genet (2000) 1.53
Human NELL-1 expressed in unilateral coronal synostosis. J Bone Miner Res (1999) 1.52
Gastrointestinal manifestations of vascular anomalies in childhood: varied etiologies require multiple therapeutic modalities. J Pediatr Surg (1998) 1.52
Klippel-Trenaunay syndrome and spinal arteriovenous malformations: an erroneous association. AJNR Am J Neuroradiol (2010) 1.49
The O.M.E.N.S. classification of hemifacial microsomia. Cleft Palate Craniofac J (1991) 1.49
Skeletal changes associated with vascular malformations. Plast Reconstr Surg (1984) 1.46
Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol (2000) 1.43
Genetic mapping of cleidocranial dysplasia and evidence of a microdeletion in one family. Hum Mol Genet (1995) 1.42
Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg (2001) 1.42
Clinical and ultrastructural studies of Romberg's hemifacial atrophy. Plast Reconstr Surg (1990) 1.40
Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. Am J Pathol (2001) 1.40
Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia. Am J Hum Genet (1999) 1.39
Computer-assisted three-dimensional planning in craniofacial surgery. Plast Reconstr Surg (1993) 1.38
In vitro characteristics of endothelium from hemangiomas and vascular malformations. Surgery (1982) 1.38
A gene for inherited cutaneous venous anomalies ("glomangiomas") localizes to chromosome 1p21-22. Am J Hum Genet (1999) 1.37
Mast cells in hemangiomas and vascular malformations. Pediatrics (1982) 1.37
Vascular malformations of the upper limb: a review of 270 patients. J Hand Surg Am (1999) 1.36
E-selectin is present in proliferating endothelial cells in human hemangiomas. Am J Pathol (1996) 1.35
Biological classification of soft-tissue vascular anomalies: MR correlation. AJR Am J Roentgenol (1991) 1.31
Four common glomulin mutations cause two thirds of glomuvenous malformations ("familial glomangiomas"): evidence for a founder effect. J Med Genet (2005) 1.30
Classification of pediatric vascular lesions. Plast Reconstr Surg (1982) 1.30
Molecular genetics of vascular malformations. Matrix Biol (2001) 1.29
Vascular anomalies. A primer for pediatricians. Pediatr Clin North Am (1998) 1.28
Sialadenitis in childhood. Am J Surg (1978) 1.27
Facial fractures in children: an analysis of 122 fractures in 109 patients. Plast Reconstr Surg (1977) 1.25
Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation (1998) 1.25
Facial infiltrating lipomatosis. Plast Reconstr Surg (2001) 1.25
Major intravenous extravasation injuries. Am J Surg (1979) 1.23
Marked female predilection in some syndromes associated with facial hemangiomas. Am J Med Genet (1994) 1.22
Isolation and characterization of human heparin. Biochemistry (1992) 1.21
The limits of tracheal resection with primary anastomosis: further anatomical studies in man. J Thorac Cardiovasc Surg (1968) 1.21
Macroglossia: a review of the condition and a new classification. Plast Reconstr Surg (1986) 1.16
Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg (1999) 1.16
Congenital hemangioma: evidence of accelerated involution. J Pediatr (1996) 1.14
Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr (1996) 1.12
Frontal plagiocephaly: synostotic, compensational, or deformational. Plast Reconstr Surg (1992) 1.08
Cerebral vasculopathy and neurologic sequelae in infants with cervicofacial hemangioma: report of eight patients. Radiology (1998) 1.07
Induced osteogenesis for repair and construction in the craniofacial region. Plast Reconstr Surg (1980) 1.07
The role of matrix metalloproteinase activity in the maturation of human capillary endothelial cells in vitro. J Cell Sci (1999) 1.05
Fate of mineralized and demineralized osseous implants in cranial defects. Calcif Tissue Int (1981) 1.05
The current management of vascular birthmarks. Pediatr Dermatol (1993) 1.04
Intracranial vascular anomalies in patients with periorbital lymphatic and lymphaticovenous malformations. AJNR Am J Neuroradiol (2007) 1.03
Complex spinal-paraspinal fast-flow lesions in CLOVES syndrome: analysis of clinical and imaging findings in 6 patients. AJNR Am J Neuroradiol (2011) 1.03
Polyethylene glycol/microfibrillar collagen composite as a new resorbable hemostatic bone wax. J Biomed Mater Res (1998) 0.99
Molecular basis of vascular anomalies. Trends Cardiovasc Med (1998) 0.98
Tissue expansion in children: a retrospective study of complications. Ann Plast Surg (1997) 0.98
Safety and clinical efficacy of Onyx for embolization of extracranial head and neck vascular anomalies. AJNR Am J Neuroradiol (2011) 0.98
The infant with a vascular tumor. Semin Perinatol (1999) 0.97
Midline cervical cleft. Plast Reconstr Surg (1985) 0.97
The selection of antibiotics for human bites of the hand. Plast Reconstr Surg (1975) 0.97
A novel association between RASA1 mutations and spinal arteriovenous anomalies. AJNR Am J Neuroradiol (2009) 0.96
Newly recognized autosomal dominant disorder with craniosynostosis. Am J Med Genet (1993) 0.96
Molding therapy for infants with deformational auricular anomalies. Ann Plast Surg (1997) 0.96
Surgical correction of hemifacial microsomia in the growing child. Plast Reconstr Surg (1988) 0.96
Surgical correction of mandibular hypoplasia in hemifacial microsomia: the case for treatment in early childhood. J Oral Maxillofac Surg (1998) 0.95
Microtia: a microform of hemifacial microsomia. Plast Reconstr Surg (1985) 0.95
Impressions of Charles Stent. Plast Reconstr Surg (1978) 0.95
Facial "glomangiomas": large facial venous malformations with glomus cells. J Am Acad Dermatol (2001) 0.94
Synostotic frontal plagiocephaly: anthropometric comparison of three techniques for surgical correction. Plast Reconstr Surg (1997) 0.94
Treacher Collins syndrome: phenotypic variability in a family including an infant with arhinia and uveal colobomas. Am J Med Genet (1996) 0.94
Vascular cutaneous anomalies in children: malformations and hemangiomas. Pediatr Surg Int (1996) 0.94
Möbius syndrome: classification and grading system. Plast Reconstr Surg (1998) 0.94
Assignment of a gene locus involved in craniosynostosis to chromosome 5qter. Hum Mol Genet (1993) 0.94
Is there an association between hemangioma and syndromes with dysmorphic features? Pediatrics (1991) 0.94
Predisposition for cysteine substitutions in the immunoglobulin-like chain of FGFR2 in Crouzon syndrome. Hum Genet (1995) 0.94
Children with repaired bilateral cleft lip/palate: effect of age at premaxillary osteotomy on facial growth. Plast Reconstr Surg (1999) 0.94
Small bowel obstruction secondary to atheromatous embolism. A case report and review of the literature. Ann Surg (1971) 0.94
Frontal plagiocephaly. Diagnosis and treatment. Clin Plast Surg (1994) 0.93
Management of facial fractures in children. Clin Plast Surg (1977) 0.93
Recessive primary congenital lymphoedema caused by a VEGFR3 mutation. J Med Genet (2009) 0.93